New Delhi, Feb. 11 -- After undergoing a lot of volatility, this pharma stock delivered stable Q3 results, and the inability of the bears to drag it lower in this uncertain market speaks well for a strong breakout as buying momentum was built. After biding some time and absorbing the volatility, we can look at the prices looking to extend next week. The steady upward bounce has pushed the RSI above 70 indicating the trends could sustain beyond the value area resistance around 700.

Also read: Gradual margin recovery to keep Apollo Tyres on tough terrain

There has been some steady buying at lower levels as the momentum tried to revive the prices from lower levels. With the cloud region offering some upward thrust, the possibility of the c...